STOCK TITAN

EyePoint (EYPT) CFO gifts 10,000 shares, including family trust holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

EyePoint, Inc. Chief Financial Officer George Elston reported non-sale insider transactions involving company common stock. On March 2, 2026, he made bona fide gift transfers totaling 10,000 shares, with 5,000 shares from his directly held stock and 5,000 shares from stock reported as indirectly held.

Footnotes explain that some shares were transferred to an irrevocable family trust for the benefit of his immediate family, with JP Morgan Trust Company of Delaware as trustee. The filing states that he disclaims beneficial ownership of the securities held in the family trust.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Elston George

(Last) (First) (Middle)
C/O EYEPOINT, INC.
480 PLEASANT STREET, SUITE C400

(Street)
WATERTOWN MA 02472

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EyePoint, Inc. [ EYPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/02/2026 G(1) 5,000 D $0.00 87,818(2) D
Common Stock 03/02/2026 G(1) 5,000 A $0.00 30,000 I By Family Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On March 2, 2026, the reporting person transferred owned shares of Common Stock of the Company to an irrevocable family trust of which JP Morgan Trust Company of Delaware is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the "Family Trust").
2. Includes 966 shares acquired on January 30, 2026, pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
3. These securities are held in a trust for the benefit of the reporting person's children. JP Morgan Trust Company of Delaware is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Remarks:
/s/ Ron Honig, Attorney-in-Fact 03/06/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did EyePoint (EYPT) report for CFO George Elston?

EyePoint reported that CFO George Elston made bona fide gifts of company common stock. The Form 4 shows two gift transactions on March 2, 2026 totaling 10,000 shares, classified as non-sale dispositions rather than open-market buying or selling.

How many EyePoint (EYPT) shares were transferred in the CFO’s March 2026 gifts?

The filing shows gift transfers totaling 10,000 shares of EyePoint common stock. One 5,000-share transaction involved directly held stock, and another 5,000-share transaction involved stock reported as indirectly held, with no cash proceeds reported for either gift.

Were EyePoint (EYPT) shares sold or gifted in the CFO’s Form 4?

The shares were gifted, not sold. Both transactions are coded as bona fide gifts at a per-share price of 0.0000, indicating transfers without sale proceeds, rather than open-market sales or purchases of EyePoint common stock.

What role does the family trust play in the EyePoint (EYPT) CFO’s holdings?

Some EyePoint securities are held in an irrevocable family trust for the benefit of the CFO’s children, with JP Morgan Trust Company of Delaware as trustee. The filing states that the reporting person disclaims beneficial ownership of the trust-held securities.

Does the EyePoint (EYPT) CFO receive proceeds from the reported Form 4 transactions?

No cash proceeds are indicated. Both transactions are reported with a transaction price per share of 0.0000 and coded as bona fide gifts, meaning the shares were transferred without a sale price or apparent cash consideration to the reporting person.

How many EyePoint (EYPT) shares does the CFO report owning after the gift transfers?

After the March 2, 2026 transactions, the Form 4 shows 87,818 shares of EyePoint common stock in direct ownership and 30,000 shares in indirect ownership via the family trust, with a disclaimer of beneficial ownership for the trust-held securities.
EyePoint

NASDAQ:EYPT

EYPT Rankings

EYPT Latest News

EYPT Latest SEC Filings

EYPT Stock Data

1.30B
77.08M
Biotechnology
Laboratory Analytical Instruments
Link
United States
WATERTOWN